---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-064700"
form_type: "8-K"
ticker: "DYN"
cik: "0001818794"
company_name: "Dyne Therapeutics, Inc."
filed_at: "2024-05-24T23:59:59+00:00"
generated_at: "2026-06-01T08:49:01.113446+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Dyne Therapeutics shareholders elect three Class I directors, ratify Deloitte as auditor

## Summary
- Carlo Incerti, M.D. elected with 61,028,245 votes for, 8,752,856 withheld, 5,235,919 broker non-votes.
- Catherine Stehman-Breen, M.D. elected with 55,026,485 votes for, 14,325,362 withheld, 5,665,173 broker non-votes.
- John G. Cox elected with 69,763,860 votes for, 32,767 withheld, 5,220,393 broker non-votes.
- Ratification of Deloitte & Touche as independent auditor for FY2024 passed with 74,962,217 for, 12,377 against, 42,426 abstain.

## SEC filing metadata
- accession: 0000950170-24-064700
- form_type: 8-K
- ticker: DYN
- cik: 0001818794
- company_name: Dyne Therapeutics, Inc.
- filed_at: 2024-05-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818794/000095017024064700/0000950170-24-064700-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818794/000095017024064700/dyn-20240522.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-064700
- JSON: https://secwatch.observer/filing/0000950170-24-064700.json
- Plain text: https://secwatch.observer/filing/0000950170-24-064700.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.